Hospital-Onset Clostridium difficile Infection Rates in Persons with Cancer or Hematopoietic Stem Cell Transplant: A C3IC Network Report
Authors:
- 1 November 2012
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 33 (11) , 1162-1165
Abstract
A multicenter survey of 11 cancer centers was performed to determine the rate of hospital-onset Clostridium difficile infection (HO-CDI) and surveillance practices. Pooled rates of HO-CDI in patients with cancer were twice the rates reported for all US patients (15.8 vs 7.4 per 10,000 patient-days). Rates were elevated regardless of diagnostic test used.Keywords
This publication has 9 references indexed in Scilit:
- Clinical and Laboratory Characteristics of Clostridium difficile Infection in Patients with Discordant Diagnostic Test ResultsJournal of Clinical Microbiology, 2012
- Vital signs: preventing Clostridium difficile infections.2012
- Diagnostic Accuracy of Real-time Polymerase Chain Reaction in Detection of Clostridium difficile in the Stool Samples of Patients With Suspected Clostridium difficile Infection: A Meta-AnalysisClinical Infectious Diseases, 2011
- Impact of PCR Testing for Clostridium difficile on Incident Rates and Potential on Public Reporting: Is the Playing Field Level?Infection Control & Hospital Epidemiology, 2011
- Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm?Bone Marrow Transplantation, 2008
- Recommendations for Surveillance of Clostridium difficile–Associated DiseaseInfection Control & Hospital Epidemiology, 2007
- A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and MortalityNew England Journal of Medicine, 2005
- Clostridium difficileInfection in Patients with NeutropeniaClinical Infectious Diseases, 2001
- Clostridium difficile Infection Associated with Antineoplastic Chemotherapy: A ReviewClinical Infectious Diseases, 1993